Skip to main content

Aprea Therapeutics, Inc.

APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001781983

No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Aprea Therapeutics, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of APRE: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders5039−11
Shares6.54M5.00M−1.54M (−23.5%)
Value$31.9M$25.6M−$6.35M (−19.9%)

New holders (6)

Institutions that held Aprea Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to APRE in Q3 2021
InstitutionSharesValue% of portfolio
Bridgeway Capital Management, LLC75,000$383.0K0.01%
Susquehanna Fundamental Investments, LLC49,100$251.0K0.00%
Verition Fund Management LLC20,101$103.0K0.00%
Blackstone Group Inc.16,590$85.0K0.00%
Jane Street Group, LLC14,159$72.0K0.00%
Koshinski Asset Management, Inc.55$2810.00%

Sold out (17)

Institutions that held Aprea Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of APRE in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
SG Americas Securities, LLC598,395$2.92M
Voloridge Investment Management, LLC152,165$743.0K
Walleye Capital LLC98,931$483.0K
Deutsche Bank AG94,386$461.0K
FIL Ltd83,191$406.0K
Charles Schwab Investment Management Inc50,366$246.0K
Virtu Financial LLC41,142$201.0K
Millennium Management LLC33,203$162.0K
Walleye Trading LLC27,455$134.0K
HRT Financial LP24,901$121.0K
Acadian Asset Management LLC18,557$91.0K
Ergoteles LLC18,570$91.0K
Great Lakes Advisors, LLC17,895$87.0K
Two Sigma Securities, LLC11,962$58.0K
Hershey Trust Co9,822$48.0K
UBS Group AG1,322$6.00K
New York State Common Retirement Fund69$0